Works matching IS 00912700 AND DT 2019 AND VI 59 AND IP 2

Results: 15

Abuse Potential of Samidorphan: A Phase I, Oxycodone‐, Pentazocine‐, Naltrexone‐, and Placebo‐Controlled Study.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 2, p. 218, doi. 10.1002/jcph.1343

By:

Pathak, Sanjeev;
Vince, Bradley;
Kelsh, Debra;
Setnik, Beatrice;
Nangia, Narinder;
DiPetrillo, Lauren;
Puhl, Matthew D.;
Sun, Lei;
Stanford, Arielle D.;
Ehrich, Elliot

Publication type:

Article

Issue Information.

Published in:: 2019
Publication type:: Table of Contents

An Evaluation of Vancomycin Area Under the Curve Estimation Methods for Children Treated for Acute Pulmonary Exacerbations of Cystic Fibrosis Due to Methicillin‐Resistant Staphylococcus aureus.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 2, p. 198, doi. 10.1002/jcph.1323

By:

Stockmann, Chris;
Olson, Jared;
Rashid, Jahidur;
Lubsch, Lisa;
Young, David C.;
Hersh, Adam L.;
Frymoyer, Adam;
Ampofo, Krow;
Liu, Xiaoxi;
Wang, Yuhuan;
Sherwin, Catherine M.T.;
Zobell, Jeffery T.

Publication type:

Article

Toward Better Understanding of Insulin Therapy by Translation of a PK‐PD Model to Visualize Insulin and Glucose Action Profiles.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 2, p. 258, doi. 10.1002/jcph.1321

By:

Schneck, Karen;
Tham, Lai San;
Ertekin, Ali;
Reviriego, Jesus

Publication type:

Article

Using a Genetic Risk Score Approach to Predict Headache Response to Triptans in Migraine Without Aura.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 2, p. 288, doi. 10.1002/jcph.1320

By:

Cargnin, Sarah;
Viana, Michele;
Sances, Grazia;
Cantello, Roberto;
Tassorelli, Cristina;
Terrazzino, Salvatore

Publication type:

Article

Chronic Kidney Disease and Third‐Generation P2Y<sub>12</sub> Inhibitors Use in Patients With Acute Coronary Syndrome: Impact on the Prognosis at 1 Year.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 2, p. 295, doi. 10.1002/jcph.1318

By:

Tello‐Montoliu, Antonio;
Ruiz‐Nodar, Juan Miguel;
Esteve‐Pastor, María Asunción;
Véliz‐Martínez, Andrea;
Orenes‐Piñero, Esteban;
Macías‐Villanego, Manuel J.;
Lozano, Teresa;
Carrillo‐Alemán, Luna;
Vicente‐Ibarra, Nuria;
Pernias‐Escrig, Vicente;
Martínez‐Martínez, Juan G.;
Rivera‐Caravaca, José Miguel;
Marín, Francisco

Publication type:

Article

Suggestions for Model‐Informed Precision Dosing to Optimize Neonatal Drug Therapy.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 2, p. 168, doi. 10.1002/jcph.1315

By:

Euteneuer, Joshua C.;
Kamatkar, Suyog;
Fukuda, Tsuyoshi;
Vinks, Alexander A.;
Akinbi, Henry T.

Publication type:

Article

Estimating Renal Function in Drug Development: Time to Take the Fork in the Road.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 2, p. 159, doi. 10.1002/jcph.1314

By:

Crass, Ryan L.;
Pai, Manjunath P.

Publication type:

Article

Changes in Health‐Related Quality of Life in People With Intellectual Disabilities Who Discontinue Long‐Term Used Antipsychotic Drugs for Challenging Behaviors.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 2, p. 280, doi. 10.1002/jcph.1311

By:

Ramerman, Lotte;
Hoekstra, Pieter J.;
Kuijper, Gerda

Publication type:

Article

Proposition of a Minimal Effective Dose of Vigabatrin for the Treatment of Infantile Spasms Using Pediatric and Adult Pharmacokinetic Data.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 2, p. 177, doi. 10.1002/jcph.1309

By:

Ounissi, Marwa;
Rodrigues, Christelle;
Bienayme, Hugues;
Duhamel, Paul;
Pons, Gérard;
Dulac, Olivier;
Nabbout, Rima;
Chiron, Catherine;
Jullien, Vincent

Publication type:

Article

A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling for the Prediction of Drug Clearance From Neonates to Adolescents.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 2, p. 189, doi. 10.1002/jcph.1310

By:

Mahmood, Iftekhar;
Tegenge, Million A.

Publication type:

Article

A Phase 1, Multiple‐Dose Study of Vedolizumab in Japanese Patients With Ulcerative Colitis.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 2, p. 271, doi. 10.1002/jcph.1307

By:

Kobayashi, Kiyonori;
Suzuki, Yasuo;
Watanabe, Kenji;
Oda, Kazunori;
Mukae, Miyuki;
Yamada, Akihiro;
Yamagami, Hirokazu;
Nishimura, Akira;
Okamoto, Hiroyuki

Publication type:

Article

Population Pharmacokinetics and Exposure‐Response Relationship of Intravenous and Subcutaneous Abatacept in Patients With Rheumatoid Arthritis.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 2, p. 245, doi. 10.1002/jcph.1308

By:

Li, Xiaohui;
Roy, Amit;
Murthy, Bindu

Publication type:

Article

Abuse Potential of Buprenorphine/Samidorphan Combination Compared to Buprenorphine and Placebo: A Phase 1 Randomized Controlled Trial.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 2, p. 206, doi. 10.1002/jcph.1280

By:

Pathak, Sanjeev;
Vince, Bradley;
Kelsh, Debra;
Shram, Megan J.;
Setnik, Beatrice;
Lu, Hong;
Nangia, Narinder;
Stanford, Arielle D.;
Ehrich, Elliot

Publication type:

Article

Dose‐Finding Studies Among Orphan Drugs Approved in the EU: A Retrospective Analysis.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 2, p. 229, doi. 10.1002/jcph.1304

By:

Schuller, Yvonne;
Gispen‐de Wied, Christine;
Hollak, Carla E. M.;
Leufkens, Hubertus G. M.;
Stoyanova‐Beninska, Violeta

Publication type:

Article